Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture

Cell Death and Disease

Volumn 2, Issue 6, 2011, Pages

  Garwood, C J ^a   Pooler, A M ^a   Atherton, J ^a   Hanger, D P ^a   Noble, W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Astrocytes; B amyloid; Inflammation; Minocycline; Tau

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3; MINOCYCLINE; TAU PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); MAPT PROTEIN, RAT; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL LOSS; CYTOKINE RELEASE; EMBRYO; ENZYME ACTIVATION; ENZYME SYNTHESIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; CELL CULTURE; CELL DEATH; CYTOLOGY; DRUG EFFECT; METABOLISM; NERVE CELL; PHOSPHORYLATION;

RATTUS;

AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; CELL DEATH; CELLS, CULTURED; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; TAU PROTEINS;

EID: 79959945013     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.50     Document Type: Article

References (42)

1. McGeer EG, McGeer PL. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimer's Dis 2010; 19: 355-361.
2. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE et al. In-vivo measurement of activated microglia in dementia. Lancet 2001; 358: 461-467. (Pubitemid 32769854)
3. Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J et al. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging 2007; 28: 1821-1833. (Pubitemid 47539700)
4. Schwab C, Klegeris A, McGeer PL. Inflammation in transgenic mouse models of neurodegenerative disorders. Biochim Biophys Acta 2010; 1802: 889-902.
5. Noble W, Hanger DP, Gallo JM. Transgenic mouse models of tauopathy in drug discovery. CNS Neurol Disord Drug Targets 2010; 9: 403-428.
6. Garwood C, Cooper JD, Hanger DP, Noble W. Anti-inflammatory effects of minocycline in a mouse model of tauopathy. Front Psych 2010; 1: 1-8.
7. Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, Hamdane M et al. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 2006; 169: 599-616. (Pubitemid 44156317)
8. Parachikova A, Vasilevko V, Cribbs DH, LaFerla FM, Green KN. Reductions in amyloidbeta- derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation. J Alzheimer's Dis 2010; 21: 527-542.
9. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006; 49: 489-502. (Pubitemid 43221886)
10. Hickman SE, Allison EK, El KJ. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008; 28: 8354-8360.
11. Jana A, Pahan K. Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease. J Neurosci 2010; 30: 12676-12689.
12. Whitney NP, Eidem TM, Peng H, Huang Y, Zheng JC. Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem 2009; 108: 1343-1359.
13. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009; 34: 4-20.
14. Van Eldik LJ, Thompson WL, Ralay RH, Behanna HA, Martin WD. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: functionbased and target-based discovery approaches. Int Rev Neurobiol 2007; 82: 277-296.
15. Mattson MP, Partin J, Begley JG. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res 1998; 807: 167-176. (Pubitemid 29005249)
16. Chung CW, Song YH, Kim IK, Yoon WJ, Ryu BR, Jo DG et al. Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol Dis 2001; 8: 162-172.
17. Noble W, Garwood C, Stephenson J, Kinsey AM, Hanger DP, Anderton BH. Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease. FASEB J 2009; 23: 739-750.
18. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 2003; 100: 10032-10037. (Pubitemid 37087063)
19. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP et al. Caspasecleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 2004; 114: 121-130. (Pubitemid 39071651)
20. Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 2007; 8: 663-672. (Pubitemid 47283144)
21. Town T, Zolton J, Shaffner R, Schnell B, Crescentini R, Wu Y et al. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro. J Neurosci Res 2002; 69: 362-372. (Pubitemid 34809485)
22. Hanger DP, Anderton BH, Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 2009; 15: 112-119.
23. Nimmerjahn A. Astrocytes going live: advances and challenges. J Physiol 2009; 587 (Part 8): 1639-1647.
24. Hatten ME. Neuronal regulation of astroglial morphology and proliferation in vitro. J Cell Biol 1985; 100: 384-396. (Pubitemid 15173244)
25. Escartin C, Bonvento G. Targeted activation of astrocytes: a potential neuroprotective strategy. Mol Neurobiol 2008; 38: 231-241.
26. Hu J, LaDu MJ, Van Eldik LJ. Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation. J Neurochem 1998; 71: 1626-1634. (Pubitemid 28443035)
27. Chen Y, Vartiainen NE, Ying W, Chan PH, Koistinaho J, Swanson RA. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J Neurochem 2001; 77: 1601-1610. (Pubitemid 32574495)
28. Cribbs DH, Poon WW, Rissman RA, Blurton-Jones M. Caspase-mediated degeneration in Alzheimer's disease. Am J Pathol 2004; 165: 353-355. (Pubitemid 38971367)
29. Cho JH, Johnson GV. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J Biol Chem 2004; 279: 54716-54723. (Pubitemid 40053216)
30. Hanger DP, Byers HL, Wray S, Leung KY, Saxton MJ, Seereeram A et al. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem 2007; 282: 23645-23654. (Pubitemid 47311907)
31. Paradisi S, Sacchetti B, Balduzzi M, Gaudi S, Malchiodi-Albedi F. Astrocyte modulation of in vitro beta-amyloid neurotoxicity. Glia 2004; 46: 252-260. (Pubitemid 38679205)
32. Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 2010; 58: 831-838.
33. Wallach D. Cell death induction by TNF: a matter of self control. Trends Biochem Sci 1997; 22: 107-109. (Pubitemid 27156937)
34. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 2006; 12: 1005-1015. (Pubitemid 44353380)
35. Tuppo EE, Arias HR. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 2005; 37: 289-305. (Pubitemid 39330191)
36. Mehlhorn G, Hollborn M, Schliebs R. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int J Dev Neurosci 2000; 18: 423-431. (Pubitemid 30243072)
37. Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT. Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. J Neuroimmunol 2000; 108: 227-235. (Pubitemid 30438772)
38. Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, Lamb BT. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 2010; 68: 19-31.
39. Lynch AM, Lynch MA. The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur J Neurosci 2002; 15: 1779-1788. (Pubitemid 35471902)
40. Mastrangelo MA, Sudol KL, Narrow WC, Bowers WJ. Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice. Am J Pathol 2009; 175: 2076-2088.
41. Pinto SS, Gottfried C, Mendez A, Goncalves D, Karl J, Goncalves CA et al. Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology. FEBS Lett 2000; 486: 203-207.
42. Kelleher I, Garwood C, Hanger DP, Anderton BH, Noble W. Kinase activities increase during the development of tauopathy in htau mice. J Neurochem 2007; 103: 2256-2267. (Pubitemid 350173566)